Almirall launches new drug in Denmark
Spain-based Almirall is launching a new drug to treat irritable bowel syndrome (IBS) – a disease area that is crowded by hopeful companies - on the Danish market.
by Henrik Tüchsen
The Spanish drug group Almirall, which is currently expanding its business in several Nordic countries, is ready to launch a new drug in Denmark. The product is – according to the company – the first drug targeting irritable bowel syndrome (IBS) in Denmark.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Spaniards close in on Leo
For abonnenter
